Pharma Veterans

 Drug Development Update – Asrar Qureshi’s Blog Post #837 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #837 for Pharma Veterans. Pharma Veterans aims to share knowledge and wisdom from Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Pavel Danilyuk Photo Credit: Pixabay Photo Credit: RF._. studio Periodically, I bring to you the update on new registrations by the USFDA. USFDA approval is most relevant because most research is happening in the US, and USFDA is mostly the first regulatory authority to approve new drugs, line extensions, new combinations, and expansion of indications. Some drugs are first applied to EMA – European Medicines Agency, but these are relatively few.  A look at new approvals is not just academic; it shows where the research is going, and where most investment is...

New Gene Therapy Products – Part 2 – Asrar Qureshi’s Blog Post #747 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #747 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Gilmer Diaz Estela Photo Credit: Thirdman Photo Credit: Tiger Lily Gene therapy is among the newest modalities of treatment. It is still an experimental treatment that works by introducing genetic material into a person’s cell to fight or prevent disease. Gene Therapy is presently being tested for several diseases, such as autoimmune disorders, hemophilia, thalassemia, Parkinson’s disease, cancer, diabetes, heart disease, and so on. Gene therapy drugs are to be given as a single dose, only once in life.  We continue to look at some more drugs. CARVY...

New Gene Therapy Products – Part 1 – Asrar Qureshi’s Blog Post #746 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #746 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Ivan Samkov Photo Credit: Google Images Gene therapy is among the newest modalities of treatment. It is still an experimental treatment that works by introducing genetic material into a person’s cell to fight or prevent disease. Gene Therapy is presently being tested for several diseases, such as autoimmune disorders, hemophilia, thalassemia, Parkinson’s disease, cancer, diabetes, heart disease, and so on. In this treatment, a gene can be delivered to a cell using a carrier called ‘vector’. Mostly, viruses are used as vectors due to their innate ability ...

Gene Therapy Progress II – Pharma Veterans’ Blog Post #519 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans’ Blog Post #519. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Continued from Previous…… The Human Genome Project, which ran from 1990 to 2003, provided researchers with the basic information about the genetic content of human organism. The discovery opened many new avenues and opportunities in various fields. Healthcare could also be a great beneficiary of genetic research. National Human Genome Research Institute, working as part of NIH in USA is focused on application of genome knowledge in healthcare. Researchers at the NHGRI are working with patients and families to better understand how genes can cause or influence diseases and develop new ...